Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation

International Journal of Cardiology

Volumn 168, Issue 5, 2013, Pages 4678-4684

  Guo, Yutao ^a,b   Wang, Haijun ^b   Zhao, Xiaoning ^b   Zhang, Yu ^b   Zhang, Dexian ^b   Ma, Jingling ^b   Wang, Yutang ^b   Lip, Gregory Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Atrial fibrillation; Bleeding; Death; Renal function; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; WARFARIN;

AGE; AGED; ARTICLE; BLEEDING; BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DEATH; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEX DIFFERENCE;

ATRIAL FIBRILLATION; BLEEDING; DEATH; RENAL FUNCTION; STROKE;

AGED; ATRIAL FIBRILLATION; CAUSE OF DEATH; CHINA; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMORRHAGE; HUMANS; INCIDENCE; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; SURVIVAL RATE; TIME FACTORS;

EID: 84886396960     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.179     Document Type: Article

References (33)

1. M. Lee, J.L. Saver, K.H. Chang, H.W. Liao, S.C. Chang, and B. Ovbiagele Low glomerular filtration rate and risk of stroke: meta-analysis BMJ 341 2010 c4249
2. R. Marinigh, D.A. Lane, and G.Y. Lip Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk J Am Coll Cardiol 57 12 2011 1339 1348
3. E.Z. Soliman, R.J. Prineas, and A.S. Go Chronic Renal Insufficiency Cohort (CRIC) Study Group. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC) Am Heart J 159 6 2010 1102 1107
4. U. Baber, V.J. Howard, and J.L. Halperin Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study Circ Arrhythm Electrophysiol 4 1 2011 26 32
5. B.A. Goldstein, C.M. Arce, M.A. Hlatky, M. Turakhia, S. Setoguchi, and W.C. Winkelmayer Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States Circulation 126 19 2012 2293 2301
6. J.B. Olesen, G.Y. Lip, and A.L. Kamper Stroke and bleeding in atrial fibrillation with chronic kidney disease N Engl J Med 367 7 2012 625 635
7. L. Friberg, L. Benson, M. Rosenqvist, and G.Y. Lip Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study BMJ 344 2012 e3522
8. M. Avgil Tsadok, C.A. Jackevicius, E. Rahme, K.H. Humphries, H. Behlouli, and L. Pilote Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation JAMA 307 18 2012 1952 1958
9. A.S. Go, M.C. Fang, and N. Udaltsova ATRIA Study Investigators. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study Circulation 119 10 2009 1363 1369
10. S.H. Hohnloser, Z. Hijazi, and L. Thomas Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial Eur Heart J 33 22 2012 2821 2830
11. M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 10 2011 883 891
12. S.H. Hohnloser, J. Oldgren, and S. Yang Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial Circulation 125 5 2012 669 676
13. E. O'Meara, P. Khairy, and M.C. Blanchet Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial Circ Heart Fail 5 5 2012 586 593
14. K. Nakagawa, T. Hirai, and S. Takashima Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation Am J Cardiol 107 6 2011 912 916
15. M. Tokuda, T. Yamane, and S. Matsuo Relationship between renal function and the risk of recurrent atrial fibrillation following catheter ablation Heart 97 2 2011 137 142
16. T.F. Chao, H.M. Tsao, and K. Ambrose Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation - the potential role beyond the CHA(2)DS(2)-VASc score Heart Rhythm 9 2012 1755 1760
17. J.P. Piccini, S.R. Stevens, and Y. Chang Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF and ATRIA study cohorts Circulation 127 2 2013 224 232
18. D. Poli, E. Antonucci, and M. Zanazzi Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics) Thromb Haemost 107 6 2012 1100 1106
19. W.C. Winkelmayer, J. Liu, S. Setoguchi, and N.K. Choudhry Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation Clin J Am Soc Nephrol 6 11 2011 2662 2668
20. A.J. Camm, G.Y. Lip, and R. De Caterina 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Associatio Europace 14 10 2012 1385 1413
21. V. Roldán, F. Marín, and H. Fernández Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding) Am J Cardiol 111 8 2013 1159 1164
22. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation Chest 137 2010 263 272
23. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864-270
24. R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. de Vos, H.J. Crijns, and G.Y. Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
25. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 12 2007 857 867
26. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
27. Y.C. Ma, L. Zuo, and J.H. Chen Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease J Am Soc Nephrol 17 2006 2937 2944
28. A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
29. J.W. Eikelboom, S.J. Connolly, and P. Gao Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease J Stroke Cerebrovasc Dis 21 6 2012 429 435
30. A. Banerjee, L. Fauchier, and P. Vourc'h Renal impairment and ischaemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project J Am Coll Cardiol 61 2013 2079 2087
31. V. Roldán, F. Marín, and S. Manzano-Fernandez Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? Thromb Haemost 109 2013 956 960
32. J. Chinda, N. Nakagawa, and M. Kabara Impact of decreased estimated glomerular filtration rate on Japanese acute stroke and its subtype Intern Med 51 13 2012 1661 1666
33. I.M. Ogilvie, N. Newton, S.A. Welner, W. Cowell, and G.Y. Lip Underuse of oral anticoagulants in atrial fibrillation: a systematic review Am J Med 123 2010 638-645.e4